RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds:: an effect reversed by GR 127935, a 5-HT1B/1D antagonist

被引:47
作者
Harrison, AA [1 ]
Parsons, LH [1 ]
Koob, GF [1 ]
Markou, A [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
5-HT1B; RU; 24969; GR; 127935; intracranial self-stimulation; reward; cocaine; serotonin;
D O I
10.1007/s002130050831
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies suggest that serotonergic neurotransmission through the serotonin-1B (5-HT1B) receptor is involved in reward processes. The purpose of the present studies was to investigate the effects of 5-HT1B receptor activation and antagonism on intracranial self-stimulation (ICSS) reward using a current-threshold ICSS task. Male Wistar rats were prepared with bipolar electrodes in the lateral hypothalamus. When stable baseline thresholds were established, the effects of the mixed 5-HT1A/1B receptor agonist, RU 24969 (0-1 mg/kg, SC), on ICSS behavior were assessed. Administration of this compound elevated ICSS thresholds without affecting response latencies, a measure of general motoric activity. The 5-HT1B/1D receptor antagonist, GR 127935 (0-10 mg/kg, SC), had no significant effect on ICSS behavior. However, pretreatment with an intermediate dose of GR 127935 (3 mg/kg), which was previously without effect on ICSS behavior, reversed the threshold-elevating effects of RU 24969 (1 mg/kg), suggesting the involvement of the 5-HT1B receptor in this effect of RU 24969 administration. Furthermore, pretreatment with RU 24969 (0.3 and 0.6 mg/kg), prior to 10 mg/kg cocaine hydrochloride, dose-dependently attenuated the threshold-reducing effects of cocaine. This result is interpreted as two opposing drug effects canceling each other out rather than a specific pharmacological antagonism. In conclusion, the results suggest that activation of 5-HT1B receptors reduces brain stimulation reward.
引用
收藏
页码:242 / 250
页数:9
相关论文
共 71 条
[1]  
[Anonymous], 1979, A Stereotaxic Atlas of the Rat Brain
[2]  
BENLOUCIF S, 1993, J PHARMACOL EXP THER, V265, P373
[3]  
BLUM K, 1969, FED PROC, V28, P794
[4]   EFFECTS OF 5-HYDROXYTRYPTOPHANE ON SELF-STIMULATION IN RATS [J].
BOSE, S ;
BAILEY, PT ;
THOA, NB ;
PRADHAN, SN .
PSYCHOPHARMACOLOGIA, 1974, 36 (03) :255-262
[5]   Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: Involvement of the hippocampo-accumbens pathway [J].
Boulenguez, P ;
Rawlins, JNP ;
Chauveau, J ;
Joseph, MH ;
Mitchell, SN ;
Gray, JA .
NEUROPHARMACOLOGY, 1996, 35 (11) :1521-1529
[6]   AUTORADIOGRAPHIC CHARACTERIZATION AND LOCALIZATION OF 5-HT(1D) COMPARED TO 5-HT(1B) BINDING-SITES IN RAT-BRAIN [J].
BRUINVELS, AT ;
PALACIOS, JM ;
HOYER, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (06) :569-582
[7]   D-3 receptor test in vitro predicts decreased cocaine self-administration in rats [J].
Caine, SB ;
Koob, GF ;
Parsons, LH ;
Everitt, BJ ;
Schwartz, JC ;
Sokoloff, P .
NEUROREPORT, 1997, 8 (9-10) :2373-2377
[8]  
CALLAHAN PM, 1995, J PHARMACOL EXP THER, V274, P1414
[9]   Modulation of the discriminative stimulus properties of cocaine: Comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists [J].
Callahan, PM ;
Cunningham, KA .
NEUROPHARMACOLOGY, 1997, 36 (03) :373-381
[10]  
CALLAWAY CW, 1992, J PHARMACOL EXP THER, V263, P318